| 应用 |
A novel metabolic modulator. |
| 产品介绍 |
Ranolazine Dihydrochloride is a novel metabolic modulator and membrane stabilizer that is an antianginal and antiischaemic agent. This compound shifts myocardial energy metabolism away from free fatty acids and toward glucose as the substrate for production of adenosine triphosphate. Ranolazine Dihydrochloride is an activator of PDK. |
| 备注 |
Ranolazine 2HCl, is an antianginal medication. |
| 生化机理 |
pFOX (partial fatty acid oxidation) inhibitor, a new class of anti-anginal drugs, which inhibit fatty acid beta-oxidation and activates pyruvate dehydrogenase, thereby diverting the heart′s energy source from lipids to glucose, which requires less oxygen and helps maintain myocardiac function at times of ischemia. |
| 别名 |
盐酸雷诺嗪;N-(2,6-二甲基苯基)-4-[2-羟基-3-(2-甲氧苯氧基)丙基]-1-哌嗪乙酰胺盐酸盐;(±) -4-[2-Hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2′,6′-xylidide dihydrochloride;N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide dihydrochloride;(RS)-N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)-propyl]piperazin-1-yl]acetamide |
